-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
Approval of the Major Science and Technology Project on “Creation of Major New Drugs”
On June 9, 2010, the Implementation and Management Office of the National Major Science and Technology Special Project for “Major New Drug Creation” issued approval notices for the three project proposals submitted by the company, in accordance with the “Approval on the Approval of 2009 Projects under the Major Science and Technology Special Project for Major New Drug Creation.” (Project approval numbers: 2008ZX09101@@-@@052; 2009ZX09103@@-@@610; 2009ZX09102@@-@@603).
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005